Inhibition of endothelial progenitor cells in the first 24 hours of an acute ischemic cerebrovascular event

Israel Medical Association Journal

Volumn 21, Issue 2, 2019, Pages 71-76

  Blum, Arnon ^a,b   Pastukh, Nina ^a   Sirchan, Rizak ^a   Blum, Nava ^c   Chernikoff, Lev ^a,b   Vaispapir, Vladimir ^a,b  

^a Poria Padeh Medical Center   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c Stern Academic College   (Israel)

Author keywords

Colonyforming units of endothelial progenitor cells (CFU EPCS); Endothelial function; Flow mediated diameter percent change (FMD ); Stroke

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; BRAIN ISCHEMIA; CELL GROWTH; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COLONY FORMATION; COLONY FORMING UNIT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; BLOOD; CEREBROVASCULAR ACCIDENT; COMPLICATION; METABOLISM; VASCULAR ENDOTHELIUM;

ADULT; BRAIN ISCHEMIA; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE;

EID: 85061714460     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Blum A, Vaispapir V, Keinan-Boker L, Soboh S, Yehuda H, Tamir S. Endothelial dysfunction and procoagulant activity in acute ischemic stroke. J Vasc Interv Neurol 2012; 5 (1): 33-9.
2. Widmer RJ, Lerman A. Endothelial dysfunction and cardiovascular disease. Glob Cardiol Sci Pract 2014; 2014 (3): 291-308.
3. Asahara T, Murohara T, Sullivan A. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997; 275: 964-7.
4. Asahara T, Takahashi T, Masuda H. VEGF contributes to postnatal neovascularization by mobilizing bone marrow derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72.
5. Hill JM, Zalos G, Halcox J, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
6. Ito H, Rovira II, Bloom ML, et al. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 1999; 59: 5875-7.
7. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
8. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-7.
9. Blum A, Blum N. Endothelial progenitor cells (EPCs) - clinical implications. J Transl Sci 2016; 2 (2): 100-6.
10. Menegazzo L, Albiero M, Avogaro A, Fadini GP. Endothelial progenitor cells in diabetes mellitus. Biofactors 2012; 38 (3): 194-202.
11. Cai-Guo Y, Zhang N, Sha-Sha Y, et al. Endothelial progenitor cells in diabetic microvascular complications: friends or foes? Stem Cell Int 2016; 2016: 1803989 doi: 10.1155/2016/1803989
12. Hernandez SL, Gong JH, Chen L, et al. Characterization of circulating and endothelial progenitor cells in patients with extreme duration type 1 diabetes. Diabetes Care 2014; 37 (8): 2193-201.
13. Werner N, Wassmann S, Ahlers P, et al. endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007; 102 (6): 565-71.
14. Lee PSS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells 2014; 6 (3): 355-66.
15. Aragona CO, Imbalzano E, Mamome F, et al. Endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease. Stem Cells Int 2016; 2016: 8043792 doi: 10.1155/2016/8043792
16. Mikirova N, Jackson JA, Hunninghake R, et al. Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Transl Med 2009; 7: 106.
17. Haddad F, Gomari FA, Wu J, Grisar JC. Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med 2011; 5 (6): 731-44.
18. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-7.
19. Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol 2002; 3: 329-33.
20. Solomon A, Blum A, Peleg A, et al. Endothelial progenitor cells are suppressed in anemic patients with acute coronary syndrome. Am J Med 2012; 125 (6): 604-11.
21. Scheubel RJ, Zorn H, Silber RE, et al. Age dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42 (12): 2073-80.
22. Cesari F, Sofi F, Molino Lova R, et al. Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenerians: effects on endothelial progenitor cells. Nutr Metal Cardiovasc Dis 2018; 28 (1): 84-90.
23. Ablin JN, Boguslavski V, Aloush V, et al. Effects of anti-TNFa treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006; 79 (25): 2364-9.
24. Blum A. Endothelial progenitor cells are affected by medications and estrogen. IMAJ 2015; 17: 578-80.
25. Levi A, Leshem-Lev D, Weissler-Snir A, et al. The effect of mineralocorticoid receptor antagonists on recruitment and function of endothelial progenitor cells in patients with congestive heart failure. IMAJ 2018; 20: 233-8.